Quetta Acquisition (QETAR) Liabilities and Shareholders Equity (2023 - 2026)
Quetta Acquisition (QETAR) posted quarterly Liabilities and Shareholders Equity of $19.6 million for Q1 2026, up 4.57% year-over-year from $18.7 million in Q1 2025, and up 1.6% quarter-over-quarter from $19.3 million in Q4 2025.
Quetta Acquisition (QETAR) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends
Quetta Acquisition (QETAR) has reported Liabilities and Shareholders Equity for 4 consecutive years, with $19.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 4.57% year-over-year to $19.6 million; the TTM figure through Mar 2026 stood at $76.9 million (down 67.96% YoY), while the FY2025 annual figure was $19.3 million, down 74.22% from the prior year.
- Liabilities and Shareholders Equity grew to $19.6 million in Q1 2026 per QETAR's latest filing, from $19.3 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $74.7 million in Q4 2024 and bottomed at $18.7 million in Q1 2025.
- Historically, Liabilities and Shareholders Equity has averaged $46.0 million across 4 years, with a median of $45.4 million in 2023.
- Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity grew 4.86% — and 2025, when it tumbled 74.22%.
- Quetta Acquisition's Liabilities and Shareholders Equity stood at $71.2 million in 2023, then gained by 4.86% to $74.7 million in 2024, then sank by 74.22% to $19.3 million in 2025, then advanced by 1.6% to $19.6 million in 2026.
- Business Quant data shows QETAR's Liabilities and Shareholders Equity at $19.6 million in Q1 2026, $19.3 million in Q4 2025, and $19.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 261.48 Mn |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 245.80 Mn |
| 3 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | 514.10 Mn |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | 464.99 Mn |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 98.35 Mn |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 247.73 Mn |
| 7 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 314.37 Mn |
| 8 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | 374.60 Mn |
| 9 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | 376.80 Mn |
| 10 | Quetta Acquisition | 1.33 Mn | 1.33 Mn | - | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.56 Mn |
| Dec 31, 2025 | 19.26 Mn |
| Sep 30, 2025 | 19.00 Mn |
| Jun 30, 2025 | 19.04 Mn |
| Mar 31, 2025 | 18.71 Mn |
| Dec 31, 2024 | 74.69 Mn |
| Sep 30, 2024 | 73.68 Mn |
| Jun 30, 2024 | 72.80 Mn |
| Mar 31, 2024 | 72.08 Mn |
| Dec 31, 2023 | 71.22 Mn |